Filter News
Area of Research
- (-) National Security (4)
- (-) Nuclear Science and Technology (2)
- Biological Systems (1)
- Biology and Environment (29)
- Clean Energy (12)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (3)
- Fusion and Fission (1)
- Isotopes (5)
- Materials (18)
- Materials for Computing (5)
- Neutron Science (19)
- Quantum information Science (9)
- Supercomputing (43)
News Topics
- (-) Biomedical (4)
- (-) Biotechnology (1)
- (-) Quantum Science (1)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (12)
- Artificial Intelligence (12)
- Big Data (6)
- Bioenergy (4)
- Biology (5)
- Buildings (1)
- Chemical Sciences (2)
- Climate Change (5)
- Computer Science (21)
- Coronavirus (3)
- Cybersecurity (19)
- Decarbonization (3)
- Energy Storage (2)
- Environment (6)
- Exascale Computing (1)
- Frontier (1)
- Fusion (9)
- Grid (6)
- High-Performance Computing (4)
- Isotopes (5)
- Machine Learning (12)
- Materials (2)
- Materials Science (6)
- Molten Salt (4)
- Nanotechnology (1)
- National Security (34)
- Neutron Science (9)
- Nuclear Energy (40)
- Partnerships (4)
- Physics (3)
- Security (11)
- Simulation (1)
- Space Exploration (5)
- Summit (2)
- Sustainable Energy (4)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
A team of researchers has developed a novel, machine learning–based technique to explore and identify relationships among medical concepts using electronic health record data across multiple healthcare providers.
ORNL scientists had a problem mapping the genomes of bacteria to better understand the origins of their physical traits and improve their function for bioenergy production.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.